Zymeworks
在场
高管
查看带有其 27 名主要高管的组织结构图
Zymeworks 搜索最多的简介
- Kenneth Galbraith, Interim Chief Financial Officer and Chief Execu...
- Troy Cox, Independent Director
- Carlos Campoy, Director
高管在Zymeworks变化
- Hollings Renton, Director, 将于 202412月10 退休 (新闻发布的2024十月22号).
- Leone PattersonLeone Patterson 将于20249月1作为 Chief Business and Financial Officer 加入公司 (新闻发布的2024七月26号).
- Chris Astle, Senior Vice President & Chief Financial Officer, 已经离开公司 (新闻发布的2024四月3号).
创建提醒
跟踪 Zymeworks 的高管变动
生物技术
Zymeworks 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Zymeworks 的最新新闻稿
- Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors | Zymeworks Inc.
- Zymeworks Announces Participation in Upcoming Investor Conferences | Zymeworks Inc.
- Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results | Zymeworks Inc.
- Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers | Zymeworks Inc.
- Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference | Zymeworks Inc.
- Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024 | Zymeworks Inc.
- Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference | Zymeworks Inc.
- News — Page 9 of 9 — Zymeworks
- Zymeworks Announces Participation in Upcoming Investor Conferences | Zymeworks Inc.
- Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock | Zymeworks Inc.
- View more press releases Close
关于 Zymeworks 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Carlos Campoy 
